​
Login / Signup
Xingcheng Yang
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Coronavirus Disease
Cell Therapy
Risk Factors
Acute Lymphoblastic Leukemia
Top Venues
American journal of hematology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Hu Qian
,
Xingcheng Yang
,
Tingting Zhang
,
Ping Zou
,
Yicheng Zhang
,
Weiwei Tian
,
Zekai Mao
,
Jia Wei
Improving the safety of CAR-T-cell therapy: The risk and prevention of viral infection for patients with relapsed or refractory B-cell lymphoma undergoing CAR-T-cell therapy.
American journal of hematology
(2024)
Hu Qian
,
Xingcheng Yang
,
Tingting Zhang
,
Ping Zou
,
Yicheng Zhang
,
Weiwei Tian
,
Zekai Mao
,
Jia Wei
Improving the safety of CAR-T-cell therapy: The risk and prevention of viral infection for patients with relapsed or refractory B-cell lymphoma undergoing CAR-T-cell therapy.
American journal of hematology
99 (4) (2024)
Hu Qian
,
Xingcheng Yang
,
Tingting Zhang
,
Ping Zou
,
Yicheng Zhang
,
Weiwei Tian
,
Zekai Mao
,
Jia Wei
Improving the safety of CAR-T-cell therapy: The risk and prevention of viral infection for patients with relapsed or refractory B-cell lymphoma undergoing CAR-T-cell therapy.
American journal of hematology
99 (4) (2024)
Hu Qian
,
Xingcheng Yang
,
Tingting Zhang
,
Ping Zou
,
Yicheng Zhang
,
Weiwei Tian
,
Zekai Mao
,
Jia Wei
Improving the safety of CAR-T-cell therapy: The risk and prevention of viral infection for patients with relapsed or refractory B-cell lymphoma undergoing CAR-T-cell therapy.
American journal of hematology
99 (4) (2024)